In 2021, the FDA approved Novo Nordisk's Wegovy, a slight reformulation of Ozempic designed specifically for weight loss, which drove a huge spike in public awareness of GLP-1 agonists
The Patient Global Impression of Improvement (PGI-I) is another useful single-question measure
( 10.2337/dc17-0417) [DOI] [PubMed] [Google Scholar] 105.Pratley RE, Aroda VR, Lingvay I, Ldemann J, Andreassen C, Navarria A, Viljoen A
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium ( via the iProX partner repository 47,48 with the dataset identifier PXD048019
An analysis of the SEER database demonstrates that DPP-4 inhibitors may improve survival outcomes in patients with colorectal and lung cancer [19]